These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38768417)

  • 1. Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data.
    Okuno T; Macwan SA; Miller D; Norman GJ; Reaven P; Zhou JJ
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38768417
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
    Dowd R; Jepson LH; Green CR; Norman GJ; Thomas R; Leone K
    JMIR Diabetes; 2023 Jan; 8():e43991. PubMed ID: 36602920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes.
    Miller E; Roberts GJ; Joseph JM; Nabutovsky Y; Reyes IJ; Souto D; Virdi N; Hirsch IB
    Am J Med Open; 2023 Jun; 9():100008. PubMed ID: 39035057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.
    Kumbara AB; Iyer AK; Green CR; Jepson LH; Leone K; Layne JE; Shomali M
    JMIR Diabetes; 2023 Sep; 8():e47638. PubMed ID: 37590491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
    Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
    J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
    Raghinaru D; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2022 Dec; 24(12):868-872. PubMed ID: 35920822
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes.
    Layne JE; Jepson LH; Carite AM; Parkin CG; Bergenstal RM
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38904213
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review.
    Gómez-Peralta F; Leiva-Gea I; Duque N; Artime E; Rubio de Santos M
    Adv Ther; 2024 Sep; 41(9):3471-3488. PubMed ID: 39093492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating Continuous Glucose Monitor Data Directly into the Electronic Health Record: Proof of Concept.
    Espinoza J; Shah P; Raymond J
    Diabetes Technol Ther; 2020 Aug; 22(8):570-576. PubMed ID: 31904260
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
    Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
    Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
    Courtney A; Smith D; Forde H
    Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
    Isitt JJ; Roze S; Tilden D; Arora N; Palmer AJ; Jones T; Rentoul D; Lynch P
    Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.